Biotin and Inlyta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Biotin (biotin) and Inlyta (axitinib). Common drug interactions include fatigue among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Biotin and Inlyta. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Biotin?

Biotin has active ingredients of biotin. It is often used in hair loss. eHealthMe is studying from 35,393 Biotin users. Check the latest studies of Biotin.

What is Inlyta?

Inlyta has active ingredients of axitinib. eHealthMe is studying from 17,662 Inlyta users. Check the latest studies of Inlyta.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

20 people who take Biotin and Inlyta together, and have interactions are studied.

What are the common drug interactions of Biotin and Inlyta, by gender? *:

female:

Fatigue (feeling of tiredness)
Arthralgia (joint pain)
Dysphonia (speech disorder attributable to a disorder of phonation)
Weight decreased
Aphonia (inability to produce voice)
Aspartate aminotransferase increased
Blood albumin decreased
Blood creatine phosphokinase decreased
Blood phosphorus increased
Blood urea increased

male:

Diarrhoea
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Myalgia (muscle pain)
Pain
Pneumonia
Rash
Weight decreased
Disease progression
Dry mouth
Dysphonia (speech disorder attributable to a disorder of phonation)

What are the common drug interactions of Biotin and Inlyta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal pain
Abdominal pain upper
Blood alkaline phosphatase increased
Constipation
Diarrhoea
Disease progression
Epistaxis (bleed from the nose)
Gamma-glutamyltransferase increased
Metastatic renal cell carcinoma (spreadable kidney cell tumour)
Nasal dryness (dry nose)

50-59:

Arthralgia (joint pain)
Cough
Dry eye (lack of adequate tears)
Dry mouth
Dysphonia (speech disorder attributable to a disorder of phonation)
Fatigue (feeling of tiredness)
Feeling of body temperature change
Glossodynia (a burning or painful sensation in the tongue)
Migraine (headache)
Oropharyngeal pain

60+:

Weight decreased
Diarrhoea
Haematoma (collection of blood outside the blood vessels)
Hyperkalaemia (damage to or disease of the kidney)
Mass
Neck pain
Neoplasm progression (growth of tumour)
Pain in extremity
Thrombosis (formation of a blood clot inside a blood vessel)
Troponin i increased

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 16 people, 80.00%
High Blood Pressure: 3 people, 15.00%
Insomnia (sleeplessness): 3 people, 15.00%
Neuropathy Peripheral (surface nerve damage): 3 people, 15.00%
Nausea (feeling of having an urge to vomit): 3 people, 15.00%
Lacrimation Increased: 2 people, 10.00%
Type 2 Diabetes: 2 people, 10.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 10.00%
Bone Pain: 2 people, 10.00%
Constipation: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Biotin and Inlyta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously